
Loading, please wait...

Loading, please wait...

Peroral endoscopic myotomy (POEM) has emerged as a cornerstone treatment for achalasia. However, confirming clinical success post-operatively is essential for long-term management. Recent research highlights how high-resolution impedance manometry (HRiM) compares to the traditional timed barium esophagram (TBE) in assessing esophageal clearance. The study analyzed 103 patients who underwent POEM and followed them for one year. Overall, the clinical success rate reached 90% at the end of the follow-up period.
Notably, both diagnostic tools showed significant improvement in esophageal clearance following the procedure. However, the specificity of high-resolution impedance manometry was considerably higher than that of barium studies. Specifically, impedance manometry demonstrated a specificity of 82%, while the esophagram showed only 59%. Furthermore, any residual bolus detected by impedance at three months predicted treatment failure at one year. Similarly, a barium bolus height of 9 cm served as a meaningful threshold for TBE. Therefore, this technology provides clinicians with a highly reproducible and reliable method for post-operative monitoring.
The high negative predictive value of 95% makes impedance a powerful tool to rule out treatment failure. Because HRiM assesses both esophageal motility and clearance simultaneously, it may reduce the need for multiple diagnostic tests. Consequently, surgeons and gastroenterologists can streamline the follow-up process. Future guidelines may incorporate these specific thresholds to improve patient outcomes in achalasia management.
High-resolution impedance manometry incorporates impedance sensors alongside traditional pressure sensors. This addition allows the device to track the movement of boluses through the esophagus in real-time. Therefore, it provides objective information on both motor function and the physical clearance of liquids.
Research indicates that any residual bolus detected via HRiM at three months post-procedure is a meaningful predictor of long-term failure. For timed barium esophagrams, a bolus height greater than 9 cm at the three-mark serves as the primary predictive threshold.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Berger A et al. Esophageal clearance assessed by high-resolution impedance manometry in achalasia: a prospective study with 1-year follow-up. Am J Gastroenterol. 2026 May 26. doi: 10.14309/ajg.0000000000004066. PMID: 42189589.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A prospective study validates HRiM as a reliable tool for assessing esophageal clearance and predicting success 1 year after POEM in achalasia patients....
3 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today